PMID: 8947069Nov 1, 1996Paper

Effects of fluticasone propionate on methacholine dose-response curves in nonsmoking atopic asthmatics

The European Respiratory Journal
S E OverbeekJ M Bogaard

Abstract

Methacholine is frequently used to determine bronchial hyperresponsiveness (BHR) and to generate dose-response curves. These curves are characterized by a threshold (provocative concentration of methacholine producing a 20% fall in forced expiratory volume in one second (PC20) = sensitivity), slope (reactivity) and maximal response (plateau). We investigated the efficacy of 12 weeks of treatment with 1,000 microg fluticasone propionate in a double-blind, placebo-controlled study in 33 atopic asthmatics. The outcome measures used were the influence on BHR and the different indices of the methacholine dose-response (MDR) curve. After 2 weeks run-in, baseline lung function data were obtained and a MDR curve was measured with doubling concentrations of the methacholine from 0.03 to 256 mg x mL(-1). MDR curves were repeated after 6 and 12 weeks. A recently developed, sigmoid cumulative Gaussian distribution function was fitted to the data. Although sensitivity was obtained by linear interpolation of two successive log2 concentrations, reactivity, plateau and the effective concentration at 50% of the plateau value (EC50) were obtained as best fit parameters. In the fluticasone group, significant changes occurred after 6 weeks with re...Continue Reading

Citations

Feb 27, 2003·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Graeme P CurrieBrian J Lipworth
May 17, 2000·Current Opinion in Pulmonary Medicine·J C KipsR A Pauwels
Dec 1, 2007·International Journal of Chronic Obstructive Pulmonary Disease·Nicola ScichiloneVincenzo Bellia
Jul 28, 1999·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·H C HoogstedenJ B Prins
Oct 16, 1999·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·J C Kips, R A Pauwels
May 21, 1999·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·V H Van Der VeldenM A Versnel
Jul 9, 2002·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·R J MeijerH A M Kerstjens
Aug 8, 2007·Pharmacology & Therapeutics·Richard A BondClive P Page
Apr 20, 2005·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Y ZhangL-O Cardell
May 16, 2014·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·W Gerald TeagueTalissa A Altes
Oct 10, 2008·The Cochrane Database of Systematic Reviews·Nick P AdamsChristopher J Cates
Dec 2, 2011·Médecine sciences : M/S·Delphine GrasIsabelle Vachier
Oct 7, 2014·Journal of Occupational and Environmental Medicine·Akshay Sood

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.